Sofosbuvir
FDA Approves Vosevi for Patients With Chronic HCV
The FDA has approved Vosevi (sofosbuvir-velpatasvir-voxilaprevir, Gilead Sciences), a single-tablet pangenotypic ...
JULY 19, 2017

Load more
The FDA has approved Vosevi (sofosbuvir-velpatasvir-voxilaprevir, Gilead Sciences), a single-tablet pangenotypic ...
JULY 19, 2017